Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Return on Tangible Equity 2011-2025 | UTHR

Current and historical return on tangible equity values for United Therapeutics (UTHR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
United Therapeutics Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-09-30 $1.27B $6.47B 19.15%
2025-06-30 $1.24B $7.06B 19.05%
2025-03-31 $1.21B $6.70B 19.68%
2024-12-31 $1.20B $6.33B 20.67%
2024-09-30 $1.11B $5.99B 19.61%
2024-06-30 $1.07B $5.58B 19.16%
2024-03-31 $1.05B $5.22B 19.00%
2023-12-31 $0.99B $5.87B 17.92%
2023-09-30 $0.90B $5.67B 17.25%
2023-06-30 $0.87B $5.37B 17.67%
2023-03-31 $0.73B $5.08B 15.64%
2022-12-31 $0.73B $4.75B 16.45%
2022-09-30 $0.71B $4.52B 16.80%
2022-06-30 $0.63B $4.27B 15.67%
2022-03-31 $0.69B $4.13B 17.84%
2021-12-31 $0.48B $3.91B 12.96%
2021-09-30 $0.46B $3.79B 13.21%
2021-06-30 $0.47B $3.60B 14.10%
2021-03-31 $0.41B $3.40B 12.76%
2020-12-31 $0.52B $3.24B 17.04%
2020-09-30 $0.47B $3.13B 16.35%
2020-06-30 $0.43B $2.94B 15.77%
2020-03-31 $0.53B $2.79B 20.37%
2019-12-31 $-0.11B $2.62B -4.32%
2019-09-30 $-0.09B $2.56B -3.83%
2019-06-30 $-0.12B $2.40B -4.87%
2019-03-31 $-0.15B $2.15B -6.12%
2018-12-31 $0.59B $2.62B 23.63%
2018-09-30 $0.54B $2.53B 23.09%
2018-06-30 $0.71B $2.52B 31.96%
2018-03-31 $0.48B $2.32B 23.80%
2017-12-31 $0.42B $2.06B 21.32%
2017-09-30 $0.51B $2.02B 26.78%
2017-06-30 $0.40B $1.73B 21.39%
2017-03-31 $0.66B $2.03B 35.38%
2016-12-31 $0.71B $1.82B 40.38%
2016-09-30 $0.71B $1.81B 41.61%
2016-06-30 $1.01B $1.77B 62.72%
2016-03-31 $0.90B $1.68B 63.57%
2015-12-31 $0.65B $1.56B 51.34%
2015-09-30 $0.66B $1.44B 56.04%
2015-06-30 $0.17B $1.01B 15.54%
2015-03-31 $0.19B $1.06B 16.17%
2014-12-31 $0.34B $1.21B 28.18%
2014-09-30 $0.20B $1.17B 16.01%
2014-06-30 $0.28B $1.16B 22.86%
2014-03-31 $0.25B $1.30B 20.31%
2013-12-31 $0.18B $1.25B 14.66%
2013-09-30 $0.29B $1.25B 25.05%
2013-06-30 $0.30B $1.15B 27.56%
2013-03-31 $0.30B $1.14B 27.83%
2012-12-31 $0.30B $1.07B 29.62%
2012-09-30 $0.26B $1.04B 26.65%
2012-06-30 $0.27B $0.99B 27.10%
2012-03-31 $0.27B $1.00B 27.30%
2011-12-31 $0.22B $0.93B 22.26%
2011-09-30 $0.18B $1.07B 19.13%
2011-06-30 $0.14B $0.99B 15.53%
2011-03-31 $0.10B $0.91B 12.31%
2010-12-31 $0.11B $0.87B 13.48%
2010-09-30 $0.09B $0.82B 12.81%
2010-06-30 $0.07B $0.77B 9.66%
2010-03-31 $0.03B $0.71B 4.06%
2009-12-31 $0.02B $0.64B 3.30%
2009-09-30 $-0.06B $0.62B -10.12%
2009-06-30 $-0.06B $0.60B -11.30%
2009-03-31 $-0.05B $0.57B -9.78%
2008-12-31 $-0.05B $0.55B -12.02%
2008-09-30 $0.03B $0.41B 7.88%
2008-06-30 $0.03B $0.36B 10.67%
2008-03-31 $0.03B $0.32B 10.25%
2007-12-31 $0.01B $0.29B 6.01%
2007-09-30 $0.07B $0.20B 41.93%
2007-06-30 $0.07B $0.17B 34.90%
2007-03-31 $0.07B $0.14B 31.08%
2006-12-31 $0.07B $0.19B 28.99%
2006-09-30 $0.05B $0.26B 17.26%
2006-06-30 $0.06B $0.29B 20.95%
2006-03-31 $0.06B $0.27B 24.46%
2005-12-31 $0.07B $0.26B 29.51%
2005-09-30 $0.04B $0.23B 21.58%
2005-06-30 $0.03B $0.20B 17.89%
2005-03-31 $0.03B $0.19B 14.47%
2004-12-31 $0.02B $0.18B 9.20%
2004-09-30 $0.01B $0.17B 3.18%
2004-06-30 $0.00B $0.16B -1.30%
2004-03-31 $-0.01B $0.15B -5.20%
2003-12-31 $-0.01B $0.15B -5.83%
2003-09-30 $-0.01B $0.16B -5.80%
2003-06-30 $-0.02B $0.16B -12.80%
2003-03-31 $-0.02B $0.15B -13.10%
2002-12-31 $-0.02B $0.16B -14.48%
2002-09-30 $-0.03B $0.16B -16.30%
2002-06-30 $-0.03B $0.17B -14.55%
2002-03-31 $-0.03B $0.18B -18.35%
2001-12-31 $-0.04B $0.18B -19.15%
2001-09-30 $-0.06B $0.19B -30.66%
2001-06-30 $-0.06B $0.20B -27.35%
2001-03-31 $-0.08B $0.21B -39.54%
2000-12-31 $-0.08B $0.22B -43.93%
2000-09-30 $-0.05B $0.24B -40.30%
2000-06-30 $-0.05B $0.11B -60.47%
2000-03-31 $-0.03B $0.12B -40.14%
1999-12-31 $-0.03B $0.05B -78.57%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $20.082B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.048B 33.06
Zoetis (ZTS) United States $53.245B 19.06
Takeda Pharmaceutical (TAK) Japan $45.470B 9.28
BeOne Medicines - (ONC) Switzerland $43.363B 212.69
Daiichi Sankyo, - (DSNKY) Japan $42.699B 21.26
Sandoz Group AG (SDZNY) Switzerland $30.385B 0.00
Merck (MKKGY) Germany $17.810B 10.98
Shionogi (SGIOY) Japan $14.955B 13.73
Neurocrine Biosciences (NBIX) United States $14.443B 34.66
Summit Therapeutics (SMMT) United States $13.904B 0.00
IPSEN (IPSEY) France $12.822B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.019B 0.00
Ionis Pharmaceuticals (IONS) United States $11.589B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.586B 0.00
Corcept Therapeutics (CORT) United States $7.946B 85.84
Stevanato Group S.p.A (STVN) Italy $6.687B 37.42
Grifols, S.A (GRFS) Spain $5.989B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.349B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.049B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.711B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.659B 17.37
Hypermarcas (HYPMY) Brazil $3.040B 20.87
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.849B 9.09
Dyne Therapeutics (DYN) United States $2.684B 0.00
Soleno Therapeutics (SLNO) United States $2.654B 0.00
Ocular Therapeutix (OCUL) United States $2.407B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.301B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.024B 23.98
Guardian Pharmacy Services (GRDN) United States $1.850B 35.62
Harrow (HROW) United States $1.511B 92.71
BioCryst Pharmaceuticals (BCRX) United States $1.491B 88.50
Collegium Pharmaceutical (COLL) United States $1.453B 7.20
Ardelyx (ARDX) United States $1.424B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.394B 0.00
Oruka Therapeutics (ORKA) United States $1.311B 0.00
Enliven Therapeutics (ELVN) United States $1.310B 0.00
Xeris Biopharma Holdings (XERS) United States $1.191B 0.00
Nektar Therapeutics (NKTR) United States $1.153B 0.00
Relay Therapeutics (RLAY) United States $1.090B 0.00
Evotec AG (EVO) Germany $1.074B 0.00
Xencor (XNCR) United States $1.066B 0.00
Cronos Group (CRON) Canada $0.938B 0.00
Theravance Biopharma (TBPH) United States $0.881B 37.00
Savara (SVRA) United States $0.875B 0.00
ARS Pharmaceuticals (SPRY) United States $0.812B 0.00
Organogenesis (ORGO) United States $0.774B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.761B 6.80
Elite Pharmaceuticals (ELTP) United States $0.725B 0.00
ProKidney (PROK) United States $0.709B 0.00
Esperion Therapeutics (ESPR) United States $0.693B 0.00
KalVista Pharmaceuticals (KALV) United States $0.688B 0.00
Lexeo Therapeutics (LXEO) United States $0.660B 0.00
Aquestive Therapeutics (AQST) United States $0.658B 0.00
4D Molecular Therapeutics (FDMT) United States $0.616B 0.00
Bioventus (BVS) United States $0.608B 12.46
Ironwood Pharmaceuticals (IRWD) United States $0.510B 12.08
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
Akebia Therapeutics (AKBA) United States $0.443B 0.00
Altimmune (ALT) United States $0.435B 0.00
Siga Technologies (SIGA) United States $0.430B 5.88
Nature's Sunshine Products (NATR) United States $0.370B 22.05
Lyell Immunopharma (LYEL) United States $0.359B 0.00
Galectin Therapeutics (GALT) United States $0.355B 0.00
USANA Health Sciences (USNA) United States $0.351B 9.79
Silence Therapeutics (SLN) United Kingdom $0.323B 0.00
Aldeyra Therapeutics (ALDX) United States $0.304B 0.00
Larimar Therapeutics (LRMR) United States $0.280B 0.00
Avalo Therapeutics (AVTX) United States $0.274B 0.00
Aclaris Therapeutics (ACRS) United States $0.273B 0.00
Pyxis Oncology (PYXS) United States $0.271B 0.00
Achieve Life Sciences (ACHV) Canada $0.233B 0.00
OmniAb (OABI) United States $0.225B 0.00
AleAnna (ANNA) United States $0.220B 0.00
Protara Therapeutics (TARA) United States $0.213B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.153B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.139B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Cassava Sciences (SAVA) United States $0.133B 0.00
Relmada Therapeutics (RLMD) United States $0.131B 0.00
Incannex Healthcare (IXHL) Australia $0.123B 0.00
Unicycive Therapeutics (UNCY) United States $0.122B 0.00
Avita Medical (RCEL) United States $0.114B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.111B 0.00
Context Therapeutics (CNTX) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
Karyopharm Therapeutics (KPTI) United States $0.097B 0.00
Prelude Therapeutics (PRLD) United States $0.096B 0.00
Champions Oncology (CSBR) United States $0.094B 34.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Lite Strategy (LITS) United States $0.072B 0.00
Acrivon Therapeutics (ACRV) United States $0.071B 0.00
Plus Therapeutics (PSTV) United States $0.070B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Fractyl Health (GUTS) United States $0.063B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
BioNxt Solutions (BNXTF) Canada $0.062B 0.00
Talphera (TLPH) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.058B 0.00
Korro Bio (KRRO) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.38
Liminatus Pharma (LIMN) United States $0.029B 0.00
Vyome Holdings (HIND) United States $0.027B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
Heatwurx (PCSA) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mangoceuticals (MGRX) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.56
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00